Article Text

Download PDFPDF
Ideal therapy for secondary mitral regurgitation: should we look under the annulus?

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors All authors contributed to initial draft and final editing of this article.

  • Funding This study was funded by the National Institute of Health/NHLBI.

  • Competing interests JH is on SAB of Chordalign. JSG is consultant for Edwards Lifesciences. GA is consultant for Abbott, Edwards Lifesciences, Medtronic and Cephea.

  • Patient consent Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles